Researchers have uncovered how chronic hepatitis C infection leads to autoimmune disease, which opens new paths for treatments ...
Rese-cel, previously called CABA-201, is a CAR T-cell therapy that's designed to treat MS by depleting B-cells.
12h
A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing ...
A recent study by Emory University researchers provides new insights into why the mRNA vaccines developed to fight COVID-19 ...
In this video, Paolo Caimi, MD, a physician and clinical investigator at Cleveland Clinic, discussed research on the use of ...
A new type of cell-based immunotherapy shows promise for B-cell lymphomas and - due to innovations in manufacturing - could make future cellular immunotherapies less expensive and more accessible to ...
Patients with relapsed or refractory large B-cell lymphoma who received epcoritamab or glofitamab in real-world settings ...
A new type of cell-based immunotherapy shows promise for B-cell lymphomas, and due to innovations in manufacturing, could ...
A phase 1 clinical trial co-led by researchers at Washington University School of Medicine in St. Louis found that a new type ...
An investigational induced pluripotent stem cell-derived CAR natural killer cell therapy was well tolerated both as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback